David M. Goldstein
CIK: 0001751719
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ALUMIS INC.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Aug 3, 2026ALMS
ALUMIS INC.
Sale(S)Direct2.6K shares at avg. $26.37$68K - Jan 26, 2026ALMS
ALUMIS INC.
Award(A)DirectStock Option (Right to Buy)
216.7K shares- - Sep 25, 2025ALMS
ALUMIS INC.
Will/Inheritance(W)Indirect1K shares- - Jul 29, 2025ALMS
ALUMIS INC.
Award(A)Direct27K shares- - Feb 18, 2025ALMS
ALUMIS INC.
Award(A)DirectStock Option (Right to Buy)
180K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 3, 2026 | ALMS ALUMIS INC. | Sale(S) | 2,596 | $26.37 | $68,457 | Direct |
| Jan 26, 2026 | ALMS ALUMIS INC. | Award(A) Stock Option (Right to Buy) | 216,675 | - | - | Direct |
| Sep 25, 2025 | ALMS ALUMIS INC. | Will/Inheritance(W) | 1,000 | - | $0 | Indirect |
| Jul 29, 2025 | ALMS ALUMIS INC. | Award(A) | 27,000 | - | - | Direct |
| Feb 18, 2025 | ALMS ALUMIS INC. | Award(A) Stock Option (Right to Buy) | 180,000 | - | - | Direct |
1-5 of 5 transactions
About Goldstein David M
Goldstein David M (SEC CIK 0001751719) files insider reports with the SEC as Chief Scientific Officer of ALUMIS INC. (ALMS).
Signal8 holds 5 ownership filings by Goldstein David M (4 Form 4, 1 Form 5), filed between Feb 20, 2025 and Aug 5, 2026. Those filings report 5 transactions, from Feb 18, 2025 to Aug 3, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Goldstein David M's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by Goldstein David M
- Aug 3, 2026: Open-market sale of ALMS shares (Form 4, code S).
- Jan 26, 2026: Grant or award of ALMS derivative securities (Form 4, code A).
- Sep 25, 2025: Will / inheritance transaction of ALMS shares (Form 5, code W).
- Jul 29, 2025: Grant or award of ALMS shares (Form 4, code A).
- Feb 18, 2025: Grant or award of ALMS derivative securities (Form 4, code A).
Other insiders filing for ALUMIS INC. (ALMS)
- AKKARAJU SRINIVAS, Director
- Schroer John R., Chief Financial Officer
- Pangali Sanam, Chief Legal Officer
- Hardiman Roy C., Chief Business & Strategy Ofcr
- Drappa Jorn, Chief Medical Officer
- Bradley Mark Christopher, Chief Development Officer